These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6188206

  • 1. Virulence factors in infections with bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide.
    Lindberg AA, Weintraub A, Kasper DL, Lönngren J.
    Scand J Infect Dis Suppl; 1982; 35():45-52. PubMed ID: 6188206
    [No Abstract] [Full Text] [Related]

  • 2. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.
    Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lönngren J.
    Rev Infect Dis; 1984; 6 Suppl 1():S25-9. PubMed ID: 6718939
    [Abstract] [Full Text] [Related]

  • 3. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.
    Kasper DL, Weintraub A, Lindberg AA, Lönngren J.
    J Bacteriol; 1983 Feb; 153(2):991-7. PubMed ID: 6185469
    [Abstract] [Full Text] [Related]

  • 4. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA, Weintraub A.
    Scand J Infect Dis Suppl; 1985 Feb; 46():27-32. PubMed ID: 3865350
    [Abstract] [Full Text] [Related]

  • 5. Endotoxins of anaerobic gram-negative rods.
    Hofstad T, Sveen K.
    Scand J Infect Dis Suppl; 1979 Feb; (19):42-5. PubMed ID: 88759
    [Abstract] [Full Text] [Related]

  • 6. Chemical composition, serological reactivity and endotoxicity of lipopolysaccharides extracted in different ways from Bacteroides fragilis, Bacteroides melaninogenicus and Bacteroides oralis.
    Hofstad T, Sveen K, Dahlén G.
    Acta Pathol Microbiol Scand B; 1977 Aug; 85(4):262-70. PubMed ID: 19922
    [Abstract] [Full Text] [Related]

  • 7. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides.
    Weintraub A, Larsson BE, Lindberg AA.
    Infect Immun; 1985 Jul; 49(1):197-201. PubMed ID: 4008048
    [Abstract] [Full Text] [Related]

  • 8. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL, Onderdonk AB.
    Scand J Infect Dis Suppl; 1982 Jul; 31():28-33. PubMed ID: 6954635
    [Abstract] [Full Text] [Related]

  • 9. Studies on the antigenic determinant group of the type-specific antigen of Leptospira canicola.
    Kasai N, Yanagawa R.
    Zentralbl Bakteriol Orig A; 1974 Sep; 228(4):533-41. PubMed ID: 4140640
    [No Abstract] [Full Text] [Related]

  • 10. [Lipopolysaccharides from Rhodospirillaceae: composition and taxonomic relevance].
    Weckesser J, Drews G, Mayer H, Fromme I.
    Zentralbl Bakteriol Orig A; 1974 Sep; 228(1):193-8. PubMed ID: 4154665
    [No Abstract] [Full Text] [Related]

  • 11. Cell wall lipopolysaccharides from Neisseria catarrhalis.
    Adams GA, Tornabene TG, Yaguchi M.
    Can J Microbiol; 1969 Apr; 15(4):365-74. PubMed ID: 5771614
    [No Abstract] [Full Text] [Related]

  • 12. Structural characterization of two surface polysaccharides of Bacteroides fragilis.
    Tzianabos AO, Pantosti A, Baumann H, Michon F, Brisson JR, Jennings HJ, Kasper DL.
    Trans Assoc Am Physicians; 1991 Apr; 104():285-95. PubMed ID: 1845153
    [No Abstract] [Full Text] [Related]

  • 13. Studies on lipopolysaccharides of Proteus.
    Dmitriev BA, Hinton NA, Lowe RW, Jones JK.
    Can J Microbiol; 1971 Nov; 17(11):1385-94. PubMed ID: 4945384
    [No Abstract] [Full Text] [Related]

  • 14. Homogeneity of lipopolysaccharides from Acholeplasma.
    Smith PF.
    J Bacteriol; 1977 Apr; 130(1):393-8. PubMed ID: 67111
    [Abstract] [Full Text] [Related]

  • 15. Studies on lipopolysaccharides of Proteus mirabilis serotypes.
    Sidorczyk Z, Kotelko K.
    Arch Immunol Ther Exp (Warsz); 1973 Apr; 21(6):829-38. PubMed ID: 4784636
    [No Abstract] [Full Text] [Related]

  • 16. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL, Onderdonk AB, Polk BF, Bartlett JG.
    Rev Infect Dis; 1979 Apr; 1(2):278-90. PubMed ID: 549184
    [Abstract] [Full Text] [Related]

  • 17. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC, McLean C, Tabaqchali S.
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [Abstract] [Full Text] [Related]

  • 18. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL.
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [Abstract] [Full Text] [Related]

  • 19. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG.
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [Abstract] [Full Text] [Related]

  • 20. 4-amino-4,6-dideoxyhexoses isolated from lipopolysaccharides of Escherichia coli.
    Jann B, Jann K.
    Eur J Biochem; 1967 Jul; 2(1):26-31. PubMed ID: 4865563
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.